Trial Profile
Fludarabine and Cytarabine Versus High-dose Cytarabine in Consolidation Treatment of Core-bing Factor Acute Myeloid Leukemia: A Prospective, Multicenter, Randomized Study
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 19 May 2022
Price :
$35
*
At a glance
- Drugs Cytarabine (Primary) ; Fludarabine (Primary)
- Indications Acute myeloid leukaemia
- Focus Therapeutic Use
- 05 May 2022 Planned End Date changed from 1 Jul 2020 to 1 Jul 2024.
- 12 Oct 2016 New trial record